neuro42, Inc receives US FDA clearance for its portable diagnostic MRI scanner, ET HealthWorld


Mumbai: neuro42, Inc announced it has received 510(k) clearance from the US Food and Drug Administration (US FDA) for its portable diagnostic MRI scanner. The MRI system eliminates the need to transport a patient to an imaging suite, enabling timely diagnosis and improving treatment outcomes for patients with critical neurological conditions.

“We are thrilled to announce the FDA clearance of our bedside MRI product,” said Abhita Batra, Founder and Chief Strategy Officer, neuro42. “Our team has been focused on making a difference in patient care, and now we can finally arm healthcare providers with a valuable tool to improve accessibility to neuroimaging.”

The company aims to expand accessibility to MRIs and streamline the diagnostic process with actionable imaging in time-sensitive environments, particularly for patients who are unable to undergo conventional MRI scans. This neuro42 MRI will be launched in the US market later this year.

Krishna Bhupal, Board of Director, neuro42 said, “neuro42 MRI is already receiving exciting reviews in India. We have gathered serious enquiries from government and private medical facilities in several states, including Telangana, Maharashtra, and Karnataka. With the FDA clearance, we will be able to serve these markets later this year.”

Bhupal said, “I look forward to the company’s next phase of growth and for it to significant player in India’s transforming healthcare ecosystem.”

  • Published On Feb 15, 2024 at 10:24 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles

Scan to download App


Leave a Reply

Your email address will not be published. Required fields are marked *